Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Medullary 1Adenocarcinoma, Follicular 1

Interventions

entrectinib 2Trastuzumab 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1sargramostim 1pembrolizumab 1mercaptoundecahydrododecaborate 1entinostat 1alectinib 1aldesleukin 1Surgical Procedures, Operative 1Semaxinib 1Ritonavir 1Radiotherapy 1Quality of Life 1Photochemotherapy 1Patient Reported Outcome Measures 1Paclitaxel 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Immunotherapy 1Gefitinib 1Fluorodeoxyglucose F18 1Fentanyl 1FAPI-46 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × Semaxinib × Endocrine × Clear all
NCT00005647 2010-06-10

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Case Comprehensive Cancer Center

Phase 1 Completed
12 enrolled
CNSEndocrineHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡